Global Hepatitis Diagnostic Test Market: Size, Share & Trends Analysis (2018-2025) - Projected to Reach $6.9 Billion - ResearchAndMarkets.com

November 7, 2018

DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “Hepatitis Diagnostic Test Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Liver Function, Immunoassays & Nucleic Acid Assays, Imaging, Liver Biopsy), And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The global hepatitis diagnostics market is expected to reach USD 6.9 billion by 2025.The non-government and government organizations play a vital role in increasing awareness of infectious diseases by conducting campaigns in order to deliver correct knowledge about the symptoms, condition, and detection techniques. Thereby, rendering a positive impact on the market growth owing to rising demand for diagnostic tests.Furthermore, the adoption of molecular biology techniques and other technologically advanced detection techniques are spurring the market growth.

Key Findings

The blood tests segment dominate the market and is expected to exhibit the fastest growth rate over the forecast period owing to their higher adoption as a first line of diagnosis.The liver function tests, sub type of blood test hold a significant share of the market since these tests are the first line diagnostics and are prerequisite for further analytical examinations required to performed for confirmation of virus causing the diseaseSome of the major players competing include, but are not limited to Abbott Laboratories, Danaher Corporation, F. Hoffmann Roche, DiaSorin S.p.A, MedMira, Inc., Siemens AG, bioMeriuex SA, Hologic, Inc., and Bio Rad Laboratories.These players dominate the market with their strong brand identity and extensive geographic reach by their strategic initiatives such as mergers & acquisition and partnership with other players.

Topics Covered

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Hepatitis Diagnostic Market Variables, Trends & Scope

Chapter 4 Hepatitis Diagnostic Market: Test Type Estimates & Trend Analysis

Chapter 5 Hepatitis Diagnostic Market: Regional Estimates & Trend Analysis

Chapter 6 Competitive Landscape

Siemens AGAbbott LaboratoriesMedMira Inc.Qaigen Inc.Beckman Coulter Inc. (Danaher Corporation)F. Hoffmann RocheDiasorin S.p.AbioMeriuexHologic Inc.Bio-Rad Laboratories Inc.

For more information about this report visit https://www.researchandmarkets.com/research/29kfg4/global_hepatitis?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005501/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Disease Testing



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/07/2018 08:13 AM/DISC: 11/07/2018 09:34 AM


Update hourly